2.47

7.39% 0.17

Tuhura Biosciences Inc (HURA)

Overview News Price History Discussions Forecast

Tuhura Biosciences Inc stock is traded at $2.47, with a volume of 317.09K. It is up +7.39% in the last 24 hours and up +3.78% over the past month. TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.

Previous Close:

$2.30

Open:

$2.29

24h Volume:

317.09K

Relative Volume:

0.65

Market Cap:

$157.30M

Revenue:

Net Income/Loss:

$-30.92M

P/E Ratio:

-4.0969

EPS:

-0.6029

Net Cash Flow:

$-27.39M

1W Performance:

+15.96%

1M Performance:

+3.78%

6M Performance:

+85.71%

1Y Performance:

-10.51%

1-Day Range:

$2.22

$2.49

1-Week Range:

$2.115

$2.58

52-Week Range:

$0.41

$3.43

Tuhura Biosciences Inc Stock (HURA) Company Profile

Name

Tuhura Biosciences Inc

Sector

Healthcare (1080)

Industry

Biotechnology (604)

Phone

813-875-6600

Address

10500 UNIVERSITY CENTER DR., TAMPA

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

HURA's Discussions on Twitter

Compare HURA vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HURA Tuhura Biosciences Inc	2.47	149.02M	0	-30.92M	-27.39M	-0.6029
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Tuhura Biosciences Inc Stock (HURA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-27-26	Initiated	Citizens	Mkt Outperform
Mar-03-25	Initiated	H.C. Wainwright	Buy
Dec-19-24	Initiated	Rodman & Renshaw	Buy
Nov-05-24	Initiated	Maxim Group	Buy

Tuhura Biosciences Inc Stock (HURA) Latest News

Aug 14, 2026

TuHURA Biosciences (NASDAQ:HURA) Posts Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat

Aug 14, 2026

TuHURA Biosciences Highlights Phase III IFx Push, AML Trial Plans at Canaccord - MarketBeat

Aug 14, 2026

TuHURA Biosciences, Inc.Common Stock (HURA) Stock Price, News, Quote & History - FinancialContent

Aug 14, 2026

TuHURA Biosciences Q2 Results: EPS beats estimate, losses narrow 33% YoY - scanx.trade

Aug 14, 2026

TuHURA Secures $50M Credit Facility Extending Cash Runway into 2028 - Minichart

Aug 14, 2026

Tuhura Biosciences Reports Second Quarter 2026 Financial Results And Provides A Corporate Update - TradingView

Aug 14, 2026

Form 8K TuHURA Biosciences Inc For: 14 August By Investing.com - Investing.com Canada

Aug 14, 2026

TuHURA Reports $1.0 Million Cash and Advances TBS-2025 AML Program - quiverquant.com

Aug 14, 2026

TuHURA Bios reports Q2 2026: $1.0M cash, R&D $6.6M, $50M credit facility extends runway - TradingView

Aug 14, 2026

TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update - PR Newswire

Aug 14, 2026

Aug 13, 2026

TuHURA Biosciences Expands Use of Revolving Credit Facility - TipRanks

Aug 13, 2026

Aug 12, 2026

TuHURA at canaccord growth conference: late-stage push gains traction By Investing.com - Investing.com Nigeria

Aug 12, 2026

TuHURA at canaccord growth conference: late-stage push gains traction - Investing.com

Aug 12, 2026

Aug 09, 2026

Enterprise value to EBIT forward of TuHURA Biosciences, Inc. – NASDAQ:HURA - TradingView

Aug 09, 2026

Aug 07, 2026

HURA Q2'26 Earnings: revenue estimate is 0 USD - TradingView

Aug 07, 2026

Aug 06, 2026

TuHURA Biosciences (HURA) Expected to Release Quarterly Earnings on Thursday - MarketBeat

Aug 06, 2026

Jul 28, 2026

TuHURA Biosciences (HURA) Dips 5.9% as Stock Tests Key Support Near $2.00Ichimoku TK Cross - dars.gov.et

Jul 28, 2026

Jul 27, 2026